As director of clinical trials, Sheth has served as principal investigator on more than 100 clinical trials, advancing ...

A real-world Vestrum database analysis found pegcetacoplan was linked to better visual acuity outcomes in geographic atrophy, ...

An AI platform that screens patient charts for clinical trial eligibility increased randomization by 37.5% and cut screen ...

Introducing Nicholas Riina, MS. Nicholas Riina, MS, had his eye on the prize early on, growing up in a family in which he was ...

ARCHER data reveal which GA eyes risk major vision loss: midrange baseline acuity and subfoveal lesions, shaping counseling ...

Arshad M. Khanani, MD, MA, discusses phase 3 SOL-1 data showing axitinib sustained vision in wet AMD for 9-12 months after 1 ...

Initiating aflibercept 8 mg or faricimab as a first-line therapy was associated with longer treatment intervals and superior ...

How equitably are glaucoma medications being dispensed across a universal health care system, and how have prescribing ...

OLN324 outperformed faricimab on anatomic outcomes as early as week 1 in the JADE trial, with no cases of intraocular ...

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Brodie about ...

Lexitas Pharma Services and Ocusun have announced enrollment of the first patient in a pilot study evaluating ZOC2017217, an ...

Published online in April in JAMA Ophthalmology, the phase 3 CONDOR trial (NCT04278417) found that brolucizumab (Beovu; ...